Fact CheckerSign in

NCT06495346Completed

Identification and Characterisation of Sleep Disorders in a Population of Patients With Non-small Cell Lung Cancer

Source: ClinicalTrials.gov · Last updated 12 Jun 2026

Brief summary (registry, in English)

This exploratory study will identify and characterise disorders frequently reported by patients as contributing to or altering their quality of life. This will enable a decision tree to be drawn up for diagnosis, referral and treatment of the sleep disorders collected, tailored to patients in this population. This decision tree should help to improve the management of patients with a cancer diagnosis presenting with sleep disorders.

Status (registry)
Completed
Study type
Observational
Enrollment
37 (actual)
First submitted
13 Feb 2024
Start date
11 Dec 2023
Primary completion date
25 Mar 2025
Lead sponsor
University Hospital, Strasbourg, France
Diseases
Lung cancer
NCT number
NCT06495346

What you commit to

  • Study type: Observational
  • Participants enrolled: 37
  • From 11 Dec 2023 to the primary completion date, 25 Mar 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • With a mental illness of the psychosis type monitored and treated prior to the study

Other

  • Patient refusing to take part in the study
  • Patient under guardianship or curatorship
  • Patient under court protection

Who the study is looking for

  • Patient aged 18 and over.
  • Being monitored and treated for non-small cell lung cancer.
  • With or without ongoing cancer-specific treatment. With no neurocognitive impairment (MoCA test score ≥26/30).
  • With a clinically assessed life expectancy of more than 3 months (Royal Marsden Hospital 0-1) and general health (ECOG \<2).
  • Able to understand the study documents written in French
  • Able to complete the study questionnaires written in French.
  • Contactable by telephone throughout the study
  • Affiliated to a social security scheme or entitled beneficiary
  • Not opposed to taking part in the study

Age in the registry: 18 years to - · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
HUS
Coordinator of this site? Confirm its status
StrasbourgFranceUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.